Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03048136
Title A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer (CheckMate 955)
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Bristol-Myers Squibb

lung non-small cell carcinoma


Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA | DEU | CAN

Additional content available in CKB BOOST